CIN3
12 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine (NCT05371353) | Shanghai Bovax Biotechnology Co., Ltd. | 2022-05-14 |
| Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years (NCT05027776) | Shanghai Bovax Biotechnology Co., Ltd. | 2021-09-15 |
| Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females (NCT05372016) | Shanghai Bovax Biotechnology Co., Ltd. | 2020-09-19 |
| Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Females (NCT04425291) | Shanghai Bovax Biotechnology Co., Ltd. | 2020-05-28 |
| Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females (NCT04422366) | Shanghai Bovax Biotechnology Co., Ltd. | 2020-04-28 |
| Cervical Cancer Screening With Human Papillomavirus Testing (NCT01881659) | International Agency for Research on Cancer | 2013-05-01 |
Track CIN3 automatically
Every clearance here is in the API, with alerts when new ones post.